FAQ Library

Join Dr. Nooka as he explains the educational resources to patients with multiple myeloma.

Join Dr. Nooka as he discusses the signs that your multiple myeloma patient may be non-adherent to their maintenance therapy.

Dr. Philip McCarthy explains the length of time maintenance therapy should last and the necessity of patient monitoring during this time.

Dr. Philip McCarthy explores the essential considerations that go into creating a survivorship plan for multiple myeloma.

Dr. Orlowski explains the difference between MRD and CR.

Dr. Stadtmauer discusses the role of the serum free light chain assay in the diagnostic workup for multiple myeloma.

The current standard of care and future DETERMINATION trial results for timing of transplantation in newly diagnosed multiple myeloma patients are discussed by Dr. Sergio Giralt.

Dr. Sagar Lonial describes how to define high-risk smoldering or asymptomatic multiple myeloma.
Dr. Raymond Comenzo explains deep sequencing PCR and what the investigational tool measures.
Dr. Raymond Comenzo explains stem cell stimulation, collection, and when it is appropriate to transplant in the treatment cycle of multiple myeloma patients.